 |
| Dr Jim Harris |
Congratulations
Dr Jim Harris who has received a grant of $48,500 from pharmaceutical company
Abbvie for his study “Autophagy in rheumatoid arthritis: effects of TNF
blockade”.
Chief
Investigator in the Lupus and Arthritis lab, Centre for Inflammatory Diseases,
Dr Harris will study autophagy in cells from patients with rheumatoid arthritis.
“In
this study we will look at the effect of TNF blockers, a common treatment for
rheumatoid arthritis (RA) on autophagy, a cellular process involved in numerous
immune cell functions,” said Dr Harris.
In
addition, Dr Harris’ group will investigate autophagic responses in cells from
patients with RA, to determine whether defects in this process might account
for some of the inflammatory pathology in these patients.
“This
is a chance for us to utilise our close connection to the rheumatology clinic
and test important regulatory mechanisms in cells from patients with RA.”
No comments:
Post a Comment